SPNE - SeaSpine Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
12.72
+0.05 (+0.39%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close12.67
Open12.66
Bid0.00 x 3100
Ask0.00 x 800
Day's Range12.57 - 12.84
52 Week Range12.07 - 20.75
Volume55,659
Avg. Volume54,658
Market Cap240.377M
Beta (3Y Monthly)-0.13
PE Ratio (TTM)N/A
EPS (TTM)-2.14
Earnings DateJul 29, 2019 - Aug 2, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.80
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    SeaSpine Announces Full Commercial Launch of Regatta® Lateral System

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Regatta® Lateral System, featuring NanoMetalene® technology. “The Regatta Lateral System is the culmination of the extensive lateral expertise of our product development and marketing teams and the valuable surgeon input gained through a comprehensive alpha evaluation,” stated Dennis Cirino, Senior Vice President, Global Spinal Systems.

  • Is SeaSpine Holdings Corporation's (NASDAQ:SPNE) CEO Being Overpaid?
    Simply Wall St.last month

    Is SeaSpine Holdings Corporation's (NASDAQ:SPNE) CEO Being Overpaid?

    Keith Valentine became the CEO of SeaSpine Holdings Corporation (NASDAQ:SPNE) in 2015. First, this article will...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of SPNE earnings conference call or presentation 1-May-19 8:30pm GMT

    Q1 2019 SeaSpine Holdings Corp Earnings Call

  • SeaSpine Holdings (SPNE) Q1 2019 Earnings Call Transcript
    Motley Fool3 months ago

    SeaSpine Holdings (SPNE) Q1 2019 Earnings Call Transcript

    SPNE earnings call for the period ending March 31, 2019.

  • SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates
    Zacks3 months ago

    SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates

    SeaSpine (SPNE) delivered earnings and revenue surprises of -14.29% and 1.20%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire3 months ago

    SeaSpine Reports First Quarter 2019 Financial Results

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended March 31, 2019 and updated its financial outlook for 2019. "We were pleased with our performance and execution in the first quarter,” said Keith Valentine, President and Chief Executive Officer.

  • ACCESSWIRE3 months ago

    SeaSpine Holdings Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 1, 2019 / SeaSpine Holdings Corp. (NASDAQ: SPNE) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 1, 2019 at 4:30 PM Eastern ...

  • Will SeaSpine Holdings (SPNE) Report Negative Earnings Next Week? What You Should Know
    Zacks3 months ago

    Will SeaSpine Holdings (SPNE) Report Negative Earnings Next Week? What You Should Know

    SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire3 months ago

    SeaSpine to Report First Quarter 2019 Financial Results on May 1, 2019

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release first quarter 2019 financial results after the close of trading on Wednesday, May 1, 2019.  Members of the Company's management team will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET to discuss the financial results and the Company’s business. Individuals interested in listening to the conference call may do so by dialing (877) 418-4766 for domestic callers or (614) 385-1253 for international callers, using Conference ID: 4492577.  To listen to a live webcast, please visit the Investors section of the SeaSpine website at: www.seaspine.com.

  • SeaSpine Holdings (NASDAQ:SPNE) Shareholders Have Enjoyed A 13% Share Price Gain
    Simply Wall St.3 months ago

    SeaSpine Holdings (NASDAQ:SPNE) Shareholders Have Enjoyed A 13% Share Price Gain

    It hasn't been the best quarter for SeaSpine Holdings Corporation (NASDAQ:SPNE) shareholders, since the share price has fallen 14% in that time. While that might be a setback, it doesn't negate the nice returns received o...

  • GlobeNewswire3 months ago

    Kuros Biosciences Reports Results for the Full Year 2018

    Financial highlights CHF 19.0 million cash & cash equivalents, trade and other receivables as at December 31, 2018Net operating costs decreased to CHF 14.3 million.

  • SeaSpine Holdings Corporation (NASDAQ:SPNE): Are Analysts Bullish?
    Simply Wall St.4 months ago

    SeaSpine Holdings Corporation (NASDAQ:SPNE): Are Analysts Bullish?

    In December 2018, SeaSpine Holdings Corporation (NASDAQ:SPNE) announced its latest earnings update, which signalled that losses became smaller relative to the prior year's level as a result of recent tailwindsRead More...

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of SPNE earnings conference call or presentation 27-Feb-19 9:30pm GMT

    Q4 2018 SeaSpine Holdings Corp Earnings Call

  • GuruFocus.com5 months ago

    SeaSpine Holdings Corp (SPNE) Files 10-K for the Fiscal Year Ended on December 31, 2018

    SeaSpine Holdings Corp (NASDAQ:SPNE) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.

  • SeaSpine Holdings Corp (SPNE) Q4 2018 Earnings Conference Call Transcript
    Motley Fool5 months ago

    SeaSpine Holdings Corp (SPNE) Q4 2018 Earnings Conference Call Transcript

    SPNE earnings call for the period ending December 31, 2018.

  • GlobeNewswire5 months ago

    SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2018 and reaffirmed revenue guidance for 2019.

  • GlobeNewswire5 months ago

    SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors

    CARLSBAD, Calif., Feb. 19, 2019 -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal.

  • GlobeNewswire5 months ago

    SeaSpine to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019

    CARLSBAD, Calif., Feb. 14, 2019 -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal.

  • GlobeNewswire5 months ago

    Kuros Biosciences Signs Agreement to Supply SeaSpine with Bone Graft Incorporating Kuros’s Advanced Submicron Surface Technology

    Kuros Biosciences (SIX:KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has signed a private label Original Equipment Manufacturer (OEM) agreement with SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders. Under the agreement Kuros will supply the bone graft in various forms and SeaSpine will market the products under the brand name OsteoCurrent in the U.S. and other select markets in Europe, South America and the Middle East providing the necessary regulatory approvals are achieved.

  • What Kind Of Shareholder Owns Most SeaSpine Holdings Corporation (NASDAQ:SPNE) Stock?
    Simply Wall St.6 months ago

    What Kind Of Shareholder Owns Most SeaSpine Holdings Corporation (NASDAQ:SPNE) Stock?

    If you want to know who really controls SeaSpine Holdings Corporation (NASDAQ:SPNE), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk Read More...

  • GlobeNewswire6 months ago

    SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018

    Preliminary and unaudited revenue for fourth quarter 2018 is expected to be in the range of $37.6 to $38.0 million, reflecting approximately 10.6% to 11.8% growth compared to the prior year period.  Fourth quarter 2018 U.S. revenue is expected to be in the range of $33.8 to $34.1 million, reflecting 8% to 9% growth compared to the fourth quarter 2017. U.S. Orthobiologics revenues are expected to reflect growth within the 9% – 10% range and U.S Spinal Implants revenues are expected to reflect growth within the 7.5% to 8.5% range for the fourth quarter.  International revenue is expected to increase more than 35% to approximately $3.8 to $3.9 million, with growth primarily driven by a recently added distributor in Australia. Cash, cash equivalents and investments at December 31, 2018 are expected to be approximately $54.0 million.  The Company raised approximately $54 million of net proceeds in October from an underwritten public offering of 3.7 million shares of common stock and used a portion of those proceeds to repay the entire $7.3 million of outstanding borrowings under its credit facility.

  • SeaSpine Holdings Corp (SPNE): Are Hedge Funds Right About This Stock?
    Insider Monkey7 months ago

    SeaSpine Holdings Corp (SPNE): Are Hedge Funds Right About This Stock?

    We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September 30th. In this article, we look at what those funds think of SeaSpine Holdings Corp (NASDAQ:SPNE) based on that […]

  • Simply Wall St.7 months ago

    Have Insiders Been Selling SeaSpine Holdings Corporation (NASDAQ:SPNE) Shares This Year?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...

  • GlobeNewswire8 months ago

    SeaSpine to Participate in the 30th Annual Piper Jaffray Healthcare Conference

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to present at the 30th Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, November 28th, 2018 at 2:00pm ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company’s website at www.seaspine.com. SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of SPNE earnings conference call or presentation 6-Nov-18 9:30pm GMT

    Q3 2018 SeaSpine Holdings Corp Earnings Call